Myelodysplastic Syndrome Updated.

Abstract excerpt

This review highlights the main changes in the revised 2016 WHO Classification of Myeloid Neoplasms (published in 2017) that impact the diagnosis and management of patients with myelodysplastic syndrome (MDS). The revision was based on data accumulated since the 2008 WHO classification of MDS, much of which relates to new molecular genetic information about these neoplasms. The new information has led to some...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Algorithms
• Share to Cytogenetics
• Share to Mutation